Literature DB >> 24233153

Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.

R Salzman, I Stárek, L Kučerová, A Skálová, J Hoza.   

Abstract

Recent research suggests that multinodular recurrent pleomorphic adenoma (PA) might result from cell migration through lymphatics. Lymphangiogenesis in malignancies is mediated by vascular endothelial growth factors C and D (VEGF-C/D). We studied the expression of VEGF-C/D in PA by immunohistochemistry as well as lymphatic vessel density (LVD). In 6 non-recurrent, 4 primary-to-recur, and 10 recurrent PAs, VEGF-C/D expression was assessed by immunohistochemistry. Staining was scored in terms of staining intensity (0 = absent to 3 = strong), and the percentage of positive tumor cells (scored as 0 (0-19 %), 1 (20-39 %), 2 (40-50 %), and 3 (60-100 %)) and a sum score were calculated. Intra- and peritumoral LVD was assessed by counting of LV after immunostaining, using the D2-40 antibody. All but one sample were VEGF-C negative. The differences in VEGF-D expression between non-recurrent, primary-to-recur, and recurrent PAs were not significant (p>0.05). VEGF-D expression did not correlate with peritumoral LVD (p>0.05). Our study revealed a significant difference between intra- and peritumoral LVD values when comparing individual and all sample groups (p=0.01). The lack of VEGF-C expression and of significant differences in VEGF-D expression and peritumoral LVD between patients with non-recurrent, primary-to-recur, and recurrent PAs does not support the lymphangiogenic local spread hypothesis

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24233153     DOI: 10.1007/s00428-013-1502-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  47 in total

1.  Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung.

Authors:  Katharina Schmid; Peter Birner; Verena Gravenhorst; Adelheid End; Silvana Geleff
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

2.  Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation.

Authors:  A J Leu; D A Berk; A Lymboussaki; K Alitalo; R K Jain
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

3.  Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma.

Authors:  Wael Swelam; Hiroko Ida-Yonemochi; Satoshi Maruyama; Kazufumi Ohshiro; Jun Cheng; Takashi Saku
Journal:  Virchows Arch       Date:  2005-04-23       Impact factor: 4.064

4.  Lymphatic metastasis in the absence of functional intratumor lymphatics.

Authors:  Timothy P Padera; Ananth Kadambi; Emmanuelle di Tomaso; Carla Mouta Carreira; Edward B Brown; Yves Boucher; Noah C Choi; Douglas Mathisen; John Wain; Eugene J Mark; Lance L Munn; Rakesh K Jain
Journal:  Science       Date:  2002-04-25       Impact factor: 47.728

5.  Lymphatic vessel density and expressions of lymphangiogenic growth factors in salivary carcinomas.

Authors:  M F Mello; A F Costa; L L Freitas; A B Soares; V C Araujo; A J Tincani; A S Martins; A Altemani
Journal:  Neoplasma       Date:  2011       Impact factor: 2.575

6.  Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis.

Authors:  Ji J Lim; Sungmin Kang; Mi R Lee; Hyun K Pai; Hye J Yoon; Jae I Lee; Sam P Hong; Chang Y Lim
Journal:  J Oral Pathol Med       Date:  2003-10       Impact factor: 4.253

7.  Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas.

Authors:  M J Currie; V Hanrahan; S P Gunningham; H R Morrin; C Frampton; C Han; B A Robinson; S B Fox
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

8.  Recurrence of pleomorphic adenoma of the parotid gland--predictive value of cadherin-11 and fascin.

Authors:  Juergen Brieger; Anne Duesterhoeft; Christoph Brochhausen; Jan Gosepath; C James Kirkpatrick; Wolf J Mann
Journal:  APMIS       Date:  2008-12       Impact factor: 3.205

9.  Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.

Authors:  Eberhard Stennert; Claus Wittekindt; Jens Peter Klussmann; Georg Arnold; Orlando Guntinas-Lichius
Journal:  Laryngoscope       Date:  2004-01       Impact factor: 3.325

10.  Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors.

Authors:  P Salven; A Lymboussaki; P Heikkilä; H Jääskela-Saari; B Enholm; K Aase; G von Euler; U Eriksson; K Alitalo; H Joensuu
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

View more
  9 in total

1.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

2.  Differing Lymphatic Vessels Density in Salivary Adenoid Cystic Carcinoma and Pleomorphic Adenoma.

Authors:  Richard Salzman; I Stárek; L Kučerová; A Skálová
Journal:  Pathol Oncol Res       Date:  2016-11-11       Impact factor: 3.201

3.  Correlation of intratumoral lymphatic microvessel density, vascular endothelial growth factor C and cell proliferation in salivary gland tumors.

Authors:  Márcia Gimenes Americo; Yonara Maria Freire Soares Marques; Milagros Del Valle El Abras Ankha; Renata Falchete do Prado; Yasmin Rodarte Carvalho
Journal:  Med Mol Morphol       Date:  2016-05-26       Impact factor: 2.309

4.  PLAG1 expression is maintained in recurrent pleomorphic adenoma.

Authors:  Beatriz Samara de Brito; Natália Giovanelli Gaspar; Erika Said Abu Egal; Celeste Sanchez-Romero; Antonio Santos Martins; Álfio José Tincani; Rogério de Oliveira Gondak; Oslei Paes de Almeida; Luiz Paulo Kowalski; Albina Altemani; Fernanda Viviane Mariano
Journal:  Virchows Arch       Date:  2016-07-06       Impact factor: 4.064

Review 5.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

6.  CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling.

Authors:  Chongyu Su; Yi Han; Hongtao Zhang; Yunsong Li; Ling Yi; Xiaojue Wang; Shijie Zhou; Daping Yu; Xiaoyun Song; Ning Xiao; Xiaoqing Cao; Zhidong Liu
Journal:  J Cell Mol Med       Date:  2018-03-13       Impact factor: 5.310

7.  Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.

Authors:  Ana Amélia de Souza; Albina Altemani; Ney Soares de Araujo; Lucas Novaes Texeira; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Clin Pathol       Date:  2019-09-26

8.  Angiogenesis and Lymphangiogenesis in Salivary Gland Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma.

Authors:  Mohammad Koochek Dezfuli; Maryam Seyedmajidi; Shima Nafarzadeh; Farzad Yazdani; Ali Bijani
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

9.  Salivary Gland Pleomorphic Adenomas Presenting With Extremely Varied Clinical Courses. A Single Institution Case-Control Study.

Authors:  Krzysztof Piwowarczyk; Ewelina Bartkowiak; Paweł Kosikowski; Jadzia Tin-Tsen Chou; Małgorzata Wierzbicka
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.